Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Somnomed Limited ( (AU:SOM) ) has issued an announcement.
Somnomed Limited announced a change in the director’s interest, with Karen Borg, a director of the company, converting 750,000 zero exercise price options into ordinary shares. This transaction reflects a strategic move in the company’s equity structure, potentially impacting shareholder value and signaling confidence in the company’s future prospects.
The most recent analyst rating on (AU:SOM) stock is a Buy with a A$0.45 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on providing innovative medical solutions. The company specializes in oral appliance therapies for the treatment of sleep-related breathing disorders, particularly obstructive sleep apnea.
Average Trading Volume: 71,893
Technical Sentiment Signal: Hold
Current Market Cap: A$180.5M
Learn more about SOM stock on TipRanks’ Stock Analysis page.